Boston Scientific JUDO 1, JUDO 3, and JUDO 6 Guidewires are intended to facilitate the placement of balloon dilatation catheters or other interventional therapeutic devices during percutaneous transluminal coronary angioplasty (PTCA) or other intravascular interventional procedures. These guidewires are not intended for use in the cerebral vasculature.

Device Description

The Boston Scientific JUDO 1, JUDO 3, and JUDO 6 Guidewires are available with a nominal diameter of 0.014 inches (0.37 mm) and in nominal lengths of 190 cm or 300 cm. The guidewires are composed of a stainless steel core wire which tapers at the distal end. The tapered distal end of the guidewire is covered with a proximal stainless steel coil and a distal platinum/nickel radiopaque coil that allows for visualization while using fluoroscopy. The proximal end of the guidewire contains a polytetrafluoroethylene (PTFE) coating and the distal portion of the wire is coated with a hydrophilic coating. The guidewires are available in a straight tip shape only.

The 190 cm guidewires are designed with a 2.1 cm friction fit extension section for exchange of Over-the-Wire systems by using the Stretch Extension Wire (K151840). The 300 cm guidewire allows exchange of therapeutic devices without the use of an extension wire or exchange system.

AI/ML Overview

This FDA 510(k) summary describes a guidewire device and its substantial equivalence to a predicate device, not an AI/ML powered device. Therefore, many of the requested categories related to AI/ML studies are not applicable.

Here's the information extracted from the document:

1. A table of acceptance criteria and the reported device performance

Acceptance Criteria	Reported Device Performance
No specific quantitative acceptance criteria are explicitly stated for "Tip Flexibility" in this summary. The general statement conveys that the device conforms to requirements.	"The result of the test provides reasonable assurance that the proposed devices with the modified distal core wire diameter have been designed and tested to assure conformance to the requirements for their intended use."

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

Sample Size: Not specified for the "Tip Flexibility" test.
Data Provenance: Not specified. This is bench testing, not clinical data, so country of origin or retrospective/prospective don't directly apply in the same way.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

Not applicable as this is bench testing of a physical medical device, not an AI/ML algorithm requiring expert ground truth for interpretation.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

Not applicable as this is bench testing of a physical medical device.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This document is for a physical guidewire device, not an AI/ML powered device.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

Not applicable. This document is for a physical guidewire device, not an AI/ML powered device.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

For "Tip Flexibility", the ground truth would be established by physical measurement and evaluation standards relevant to guidewire function, likely against pre-defined engineering specifications. The document doesn't detail these specific standards.

8. The sample size for the training set

Not applicable. This is not an AI/ML powered device, so there is no training set in that context.

9. How the ground truth for the training set was established

Not applicable. This is not an AI/ML powered device.

Summary

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" in a square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION".

April 12, 2018

Boston Scientific Nikki Ibis Principal Regulatory Affairs Specialist Three Scimed Place Maple Grove, Minnesota 55311-1566

Re: K180795

Trade/Device Name: JUDO 1 Guidewire, JUDO 3 Guidewire, JUDO 6 Guidewire Regulation Number: 21 CFR 870.1330 Regulation Name: Catheter Guide Wire Regulatory Class: Class II Product Code: DOX Dated: March 23, 2018 Received: March 27, 2018

Dear Nikki Ibis:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);

{1}------------------------------------------------

and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

Kenneth J. Cavanaugh -S

for

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Indications for Use	Form Approved: OMB No. 0910-0120Expiration Date: 06/30/2020See PRA Statement below.
510(k) Number (if known)	K180795
Device Name	JUDOTM 1 GuidewireJUDOTM 3 GuidewireJUDOTM 6 Guidewire
Indications for Use (Describe)	Boston Scientific JUDO 1, JUDO 3, and JUDO 6 Guidewires are intended to facilitate the placement of balloon dilatationcatheters or other interventional therapeutic devices during percutaneous transluminal coronary angioplasty (PTCA) orother intravascular interventional procedures. These guidewires are not intended for use in the cerebral vasculature.
Type of Use (Select one or both, as applicable)	Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number."

FORM FDA 3881 (7/17)	Page 1 of 1
----------------------	-------------

134000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000

{3}------------------------------------------------

510(k) Summary

per 21 CFR §807.92

Sponsor:	Boston Scientific Corporation300 Boston Scientific WayMarlborough, Massachusetts 01752USA
Contact Name andInformation	Nikki M IbisThree Scimed PlaceMaple Grove, MN 55311-1566Phone: 763-494-2381Fax: 763-494-2981e-mail: Nikki.Ibis@bsci.com
Prepared	23 March 2018
Proprietary Name	JUDO™ 1 GuidewireJUDO™ 3 GuidewireJUDO™ 6 Guidewire
Common Name	Catheter Guide Wire
Product Code	DQX
Classification	Class II, 21 CFR Part 870.1330
Predicate Device	Hornet™ Guidewire	K152231	12 February 2016
ReferenceDevice(s)	Hornet™ 10 GuidewireHornet™ 14 Guidewire	K152231	12 February 2016

{4}------------------------------------------------

Device Description

Indications for Use / Intended Use

Comparison of Technological Characteristics

The JUDO 1, JUDO 3, and JUDO 6 Guidewires incorporate substantially equivalent design, packaging, fundamental technology, manufacturing processes, sterilization process and intended use as those featured in the predicate, Hornet™ Guidewire, K152231.

Non-Clinical Test Summary

Bench testing was performed to support a determination of substantial equivalence. The result of the test provides reasonable assurance that the proposed devices with the modified distal core wire diameter have been designed and tested to assure conformance to the requirements for their intended use. No new safety or performance issues were raised during the testing.

The following device performance test was completed:

Tip Flexibility

{5}------------------------------------------------

Conclusion

Based on the indications for use, technological characteristics, safety and performance testing, the JUDO™ 1 Guidewire, JUDO™ 3 Guidewire, and JUDO™ 6 Guidewires are appropriate for the stated intended use and are considered to be substantially equivalent to the predicate device (K152231).

Regulation Number and Section

§ 870.1330 Catheter guide wire.

(a)
Identification. A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel.(b)
Classification. Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.